Davis GL. Hepatitis C. In Schiff ER, Maddrey W, Sorrell M, eds. Schiff’s Diseases of the Liver, 9th ed. Baltimore: Lippincott Williams & Wilkins, 2002:807–861.

Davis GL. Managing complications of cirrhosis. Rev Gastroenterol Disord 2002;2(3):143–145.
Davis GL. Monitoring of viral levels during therapy of hepatitis C. Hepatology 2002;36(5 Suppl 1):S145–S151.

Davis GL. Update on the management of chronic hepatitis B. Rev Gastroenterol Disord 2002;2(3):106–115.

Keeffe EB, Davis GL. Best of the AASLD. Highlights from the 52nd Annual Meeting of the American Association for the Study of Liver Diseases. November 9–13, 2001, Dallas, TX. Rev Gastroenterol Disord 2002;2(1):34–40.

McHutchison JG, Poynard T, Esteban-Mur R, Davis GL, Goodman ZD, Harvey J, Ling MH, Garaud JJ, Albrecht JK, Patel K, Dienstag JL, Morgan T. Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin. Hepatology 2002;35:688–693.

History

Adams RH, Beck JM. Obstetrics and gynecology at Baylor University Medical Center. BUMC Proceedings 2002;15:268–274.

Free MM. The aging of America: culture, stress, and sex. BUMC Proceedings 2002;15:74–76.

Guill CK. An African experience: my medical rotation in Swaziland. BUMC Proceedings 2002;15:262–267.

Hood AW. Factors that affect the educator's role. In O’Shea KL, ed. Staff Development Nursing Secrets. Philadelphia: Hanley & Belfus Inc, 2002: chapter 3.

Pergolizzi JV, DeAngelis CD, Sox H, Tansey MJB, Mills R, Ramsay MAE, Flather M. Clinical trial data: ownership, access and publication. A roundtable discussion. Clinical Researcher 2002;2:20–30.

Ramsay MAE. Responsible research: the clinical trials office. Clinical Researcher 2002;2:4–5.

Ramsay MAE. Will stem cells transform medicine? BUMC Proceedings 2002;15:135–137.

Snoots WM. Information technology and the medical profession: a curse or an opportunity? BUMC Proceedings 2002;15:138–140.

Solomon M Jr. Surgical mission work: an inside perspective. BUMC Proceedings 2002;15:147–153.